Volume 12 - Issue 11 - November, 2004
06/19/2008
Discussion group members responded to the questions below, and emails are included for any questions readers may have regarding a particular lab's policies. If you'd like to join our group, please sen an e-mail to cathlabdigest@aol.com
Discussion group members responded to...
Group Members Respond to...Defining a "normal" cath
Creating in-house criteria a goal
Re: Your question 1. A lack of any significant coronary vascular disease (lesions of
Re: question 2. I've no idea on the generally accepted numbers...
Group Members Respond to...Defining a "normal" cath
Creating in-house criteria a goal
Re: Your question 1. A lack of any significant coronary vascular disease (lesions of
Re: question 2. I've no idea on the generally accepted numbers...
Group Members Respond...
06/19/2008
Cath Lab Digest
06/19/2008
Frances Farmer, RN; Teresa Toering, MA; Marcie Gruchevsky, RN; Claudio Manubens, MD; Patti Lawrence; Laurence hearn; Stephanie Hardy, RN; Jorge Molina, RCIS
Our facility is no exception. Florida Cath Lab is a small outpatient cardiovascular catheterization facility located in Orlando, Florida. The facility is a freestanding lab with a small staff that includes one ARRT, one RCIS, three RNs, and a...
Our facility is no exception. Florida Cath Lab is a small outpatient cardiovascular catheterization facility located in Orlando, Florida. The facility is a freestanding lab with a small staff that includes one ARRT, one RCIS, three RNs, and a...
Our facility is no exception....
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Discussion group members responded to the questions below, and emails are included for any questions readers may have regarding a particular lab's policies. If you'd like to join our group, please sen an e-mail to cathlabdigest@aol.com
Discussion group members responded to...
Group Members Respond to...Defining a "normal" cath
Creating in-house criteria a goal
Re: Your question 1. A lack of any significant coronary vascular disease (lesions of
Re: question 2. I've no idea on the generally accepted numbers...
Group Members Respond to...Defining a "normal" cath
Creating in-house criteria a goal
Re: Your question 1. A lack of any significant coronary vascular disease (lesions of
Re: question 2. I've no idea on the generally accepted numbers...
Group Members Respond...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Marcie Gruchevsky, RN; Claudio Manubens, MD; Patti Lawrence; Laurence hearn; Stephanie Hardy, RN; Jorge Molina, RCIS; Frances Farmer, RN; Teresa Toering, MA
Our facility is no exception. Florida Cath Lab is a small outpatient cardiovascular catheterization facility located in Orlando, Florida. The facility is a freestanding lab with a small staff that includes one ARRT, one RCIS, three RNs, and a...
Our facility is no exception. Florida Cath Lab is a small outpatient cardiovascular catheterization facility located in Orlando, Florida. The facility is a freestanding lab with a small staff that includes one ARRT, one RCIS, three RNs, and a...
Our facility is no exception....
06/19/2008
Cath Lab Digest
06/19/2008
John Hodgson, MD, FSCAI, FACC
New IVUS Codes Were Adopted October 1
On October 1, 2004, Medicare adopted new intravascular ultrasound (IVUS) inpatient ICD-9-CM procedure codes to more accurately reflect the use of IVUS in hospitals. The new coding was developed through...
New IVUS Codes Were Adopted October 1
On October 1, 2004, Medicare adopted new intravascular ultrasound (IVUS) inpatient ICD-9-CM procedure codes to more accurately reflect the use of IVUS in hospitals. The new coding was developed through...
New IVUS Codes Were Adopted...
06/19/2008
Cath Lab Digest
06/19/2008
Mathew J. Johnson
In the J. Gerard Mudd Cardiac Catheterization Laboratory, we perform a wide range of diagnostic and interventional procedures, including right and left heart catheterization (PTCA), atherectomy, aortic and mitral valvuloplasty, coronary and...
In the J. Gerard Mudd Cardiac Catheterization Laboratory, we perform a wide range of diagnostic and interventional procedures, including right and left heart catheterization (PTCA), atherectomy, aortic and mitral valvuloplasty, coronary and...
In the J. Gerard Mudd Cardiac...
06/19/2008
Cath Lab Digest
06/19/2008
Questions for...Richard J. Gray, MD, FACC, Medical Director, Sutter Pacific Heart Centers
San Francisco, California
How has your role evolved as the center was being built and then opened to patients?
My background is that of a clinical...
Questions for...Richard J. Gray, MD, FACC, Medical Director, Sutter Pacific Heart Centers
San Francisco, California
How has your role evolved as the center was being built and then opened to patients?
My background is that of a clinical...
Questions for...Richard J. Gray,...
06/19/2008
Cath Lab Digest
06/19/2008
John Lasala, MD, PhD, FACC, FACP
Some current clinical trials use late loss as a key data point. Can you help us understand what late loss is?
Late loss is the difference in millimeters between the diameter of a stented segment post-procedure compared with the follow-up...
Some current clinical trials use late loss as a key data point. Can you help us understand what late loss is?
Late loss is the difference in millimeters between the diameter of a stented segment post-procedure compared with the follow-up...
Some current clinical trials use...
06/19/2008
Cath Lab Digest
06/19/2008
Jacques R. Sequin
As a result, in 1999, I began developing what is now the ReValving system stent. After developing the initial steps of this concept, I decided to stop surgery and devote all my time to CoreValve, because I knew that if we could achieve a...
As a result, in 1999, I began developing what is now the ReValving system stent. After developing the initial steps of this concept, I decided to stop surgery and devote all my time to CoreValve, because I knew that if we could achieve a...
As a result, in 1999, I began...
06/19/2008
Cath Lab Digest
Feature
Infographic
06/19/2008
Boston Scientific Announces FDA Clearance For New IQ Guide Wire
Boston Scientific Corporation has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary IQ Guide Wire in the United States. The...
Boston Scientific Announces FDA Clearance For New IQ Guide Wire
Boston Scientific Corporation has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary IQ Guide Wire in the United States. The...
Boston Scientific Announces FDA...
06/19/2008
Cath Lab Digest
